IAPCD

This program is best viewed in Internet Explorer.

This series of three accredited webinars will focus on recent evidence and advances impacting clinical practice in chronic pain and dependency.

In many cases, opioids are an effective therapy for the management of moderate-to-severe chronic pain. Although popular belief often exaggerates the relationship between opioids and addiction, the risk does exist. It is necessary, therefore, for the practitioner to be aware of the latest advances in addiction research, aberrant behaviors that may be indicative of the disease of addiction or which may play a part in the process of drug diversion, and the key clinical challenges when managing pain and addiction. Additionally, the practitioner must recognize that not all aberrant behaviors are caused by addiction, abuse, or misuse. In particular, pseudoaddiction may lead to symptoms similar to those of addiction, but these behaviors easily resolve upon obtaining adequate pain management. It is the right of every patient to receive adequate pain management; the pain practitioner is better able to fulfill this patient right when aberrant behaviors are appropriately addressed.

The three topics to be discussed in this series include:

1. Clinical Aspects of Risk Management in Opioid Prescribing
   
2. Neurobiology, Genetics, and Neuroimaging
   
3. Challenges in Clinical Practice

IAPCD is pleased to offer Advances in Pain and Addiction, a set of three webinars developed to highlight and discuss these important issues in chronic pain management and addiction medicine.

Advances in Pain and Addiction I: Clinical Aspects of Risk Management in Opioid Prescribing Scott M. Fishman, MD, and Steven D. Passik, PhD
Release Date: February 09, 2011 Expiration Date: February 09, 2012
Dr. Fishman leads a discussion in which Dr. Passik talks about the elements of a comprehensive assessment and risk monitoring strategy which could be accommodated into your everyday clinical routine. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Purdue Pharma.

Advances in Pain and Addiction II: Chronic Pain and Opioid Addiction-Emerging Disease States Driven By Advances in Neurobiology, Genetics, and Neuroimaging Scott M. Fishman, MD, and Edward Bilsky, PhD
Release Date: February 28, 2011 Expiration Date: February 28, 2012
Dr. Fishman leads a discussion with Dr. Bilsky who discusses the supporting research to mitigate the impact of a number of significant clinical issues continuing to hamper the effective use of opioid analgesics, including common opioid-related side effects, such as constipation and respiratory depression, and the development of tolerance, dependence, addiction, and hyperalgesia. Dr. Bilsky also provides new insights into the advances in neuroscience, receptor interactions, and functional neuroimaging. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Purdue Pharma.

Advances in Pain and Addiction III: Challenges in Clinical Practice: Ten Commandments of Opioid Prescribing; Safe, Effective and Responsible Approaches Scott M. Fishman, MD and B. Todd Sitzman, MD, MPH
Release Date: May 27, 2011 Expiration Date: May 27, 2012
Dr. Fishman leads a discussion with Dr. Sitzman who discusses the key clinical challenges which clinicians face when managing chronic pain with long-term opioids. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Purdue Pharma.